ROST
68
-3
ITW
40
3
MMM
52
-4
MCHP
58
11
VRSK
32
2
MDLZ
26
-2
XOM
50
5
CHD
35
-5
VTR
69
2
EA
44
-3
PFG
55
2
TEL
69
3
AES
54
7
EXR
26
2
D
35
-6
V
54
2
OI
58
11
HBAN
87
5
HAL
54
4
NOV
55
3
ROST
68
-3
ITW
40
3
MMM
52
-4
MCHP
58
11
VRSK
32
2
MDLZ
26
-2
XOM
50
5
CHD
35
-5
VTR
69
2
EA
44
-3
PFG
55
2
TEL
69
3
AES
54
7
EXR
26
2
D
35
-6
V
54
2
OI
58
11
HBAN
87
5
HAL
54
4
NOV
55
3
Financhill
Back

Nuveen Credit Strategies Income Fund Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Buy
62

JQC
Nuveen Credit Strategies Income Fund

Last Price:
$5.03
Seasonality Move:
0.94%
Buy
64

LYEL
Lyell Immunopharma, Inc.

Last Price:
$38.36
Seasonality Move:
-16.78%
Buy
62
Nuveen Credit Strategies Income Fund (JQC) is a Buy

Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?

  • The current Nuveen Credit Strategies Income Fund [JQC] share price is $4.99. The Score for JQC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • JQC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

JQC Stock Price Chart

What is Nuveen Credit Strategies Income Fund's stock price today?

  • The Nuveen Credit Strategies Income Fund share price today is $4.99
    The current trend is relatively stagnant and JQC is experiencing selling pressure, which indicates risk of future bearish movement.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.

JQC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 40.52 Sell
Chaikin Money Flow: -1277009 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.98 - 5.08) Sell
Bollinger Bands (100): (5.04 - 5.44) Sell

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.08 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: -97373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 32.35) Buy
Bollinger Bands (100): (10.77 - 23.75) Buy

JQC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.01 Sell
20-day SMA: 5.05 Sell
50-day SMA: 5.06 Sell
200-day SMA: 5.28 Sell
8-day EMA: 5.01 Sell
20-day EMA: 5.03 Sell
50-day EMA: 5.09 Sell
200-day EMA: 5.28 Sell

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.51 Buy
20-day SMA: 28.33 Buy
50-day SMA: 21.67 Buy
200-day SMA: 13.52 Buy
8-day EMA: 33.02 Buy
20-day EMA: 28.99 Buy
50-day EMA: 23.45 Buy
200-day EMA: 17.42 Buy

Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

Nuveen Credit Strategies Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):